BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in BBIO / BridgeBio Pharma, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 33,537 shares of BridgeBio Pharma, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (BBIO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBIO / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -33,537 -100.00 0 -100.00
2025-11-12 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 33,537 2,788 9.07 1,742 31.20 0.0031
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 30,749 17,912 139.53 1,328 199.55 0.0029
2025-05-14 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 12,837 -220,300 -94.49 444 -93.07 0.0013
2025-05-14 2024-12-31 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 233,137 108,235 86.66 6,397 101.16 0.0146
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 233,137 108,235 6,397 0.0158
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 124,902 124,902 3,180 0.0091
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -48,540 -100.00 0 -100.00
2023-11-09 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 48,540 -58,291 -54.56 1,280 -30.32 0.0043
2023-08-09 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 106,831 -12,902 -10.78 1,837 -7.46 0.0059
2023-05-12 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 119,733 119,733 1,985 0.0072
2022-11-09 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -83,858 -100.00 0 -100.00
2022-08-11 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 83,858 54,883 189.42 761 158.84 0.0012
2022-05-12 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 28,975 -78,101 -72.94 294 -83.54 0.0003
2022-02-11 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 107,076 107,076 1,786 0.0014
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA COM Call 273,900 -6.61 20,951 37.52 n/a n/a n/a
2025-11-12 2025-09-30 13F BRIDGEBIO PHARMA COM Call 293,300 -8.29 15,234 10.33 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Call 319,800 -34.10 13,809 -17.69 n/a n/a n/a
2025-05-14 2025-03-31 13F BRIDGEBIO PHARMA COM Call 485,300 -40.80 16,777 -25.42 n/a n/a n/a
2025-05-14 2024-12-31 13F/A BRIDGEBIO PHARMA COM Call 819,800 19.75 22,495 29.07 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Call 819,800 22,495 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Call 684,600 12.38 17,430 12.95 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Call 609,200 9.92 15,431 -9.94 n/a n/a n/a
2024-05-10 2024-03-31 13F BRIDGEBIO PHARMA COM Call 554,200 18.95 17,136 -8.90 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Call 465,900 19.61 18,808 83.12 n/a n/a n/a
2023-11-09 2023-09-30 13F BRIDGEBIO PHARMA COM Call 389,500 1.99 10,271 56.38 n/a n/a n/a
2023-08-09 2023-06-30 13F BRIDGEBIO PHARMA COM Call 381,900 77.46 6,569 84.08 n/a n/a n/a
2023-05-12 2023-03-31 13F BRIDGEBIO PHARMA COM Call 215,200 501.12 3,568 1,211.76 n/a n/a n/a
2023-02-09 2022-12-31 13F BRIDGEBIO PHARMA COM Call 35,800 -73.06 273 -79.41 n/a n/a n/a
2022-11-09 2022-09-30 13F BRIDGEBIO PHARMA COM Call 132,900 33.17 1,321 45.81 n/a n/a n/a
2022-08-11 2022-06-30 13F BRIDGEBIO PHARMA COM Call 99,800 -37.70 906 -44.28 n/a n/a n/a
2022-05-12 2022-03-31 13F BRIDGEBIO PHARMA COM Call 160,200 -52.56 1,626 -71.13 n/a n/a n/a
2022-02-11 2021-12-31 13F BRIDGEBIO PHARMA COM Call 337,700 1,874.85 5,633 603.25 n/a n/a n/a
2021-11-12 2021-09-30 13F BRIDGEBIO PHARMA COM Call 17,100 29.55 801 -0.50 n/a n/a n/a
2021-08-10 2021-06-30 13F BRIDGEBIO PHARMA COM Call 13,200 -65.35 805 -65.70 n/a n/a n/a
2021-05-12 2021-03-31 13F BRIDGEBIO PHARMA COM Call 38,100 -20.79 2,347 -31.37 n/a n/a n/a
2021-02-10 2020-12-31 13F BRIDGEBIO PHARMA COM Call 48,100 55.66 3,420 195.08 n/a n/a n/a
2020-11-12 2020-09-30 13F BRIDGEBIO PHARMA COM Call 30,900 -70.82 1,159 -66.43 n/a n/a n/a
2020-08-13 2020-06-30 13F BRIDGEBIO PHARMA COM Call 105,900 250.66 3,453 294.18 n/a n/a n/a
2020-05-13 2020-03-31 13F BRIDGEBIO PHARMA COM Call 30,200 876 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F BRIDGEBIO PHARMA COM Put 83,000 -6.00 6,349 38.42 n/a n/a n/a
2025-11-12 2025-09-30 13F BRIDGEBIO PHARMA COM Put 88,300 -16.06 4,586 0.97 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Put 105,200 -8.36 4,543 14.47 n/a n/a n/a
2025-05-14 2025-03-31 13F BRIDGEBIO PHARMA COM Put 114,800 -35.97 3,969 -19.33 n/a n/a n/a
2025-05-14 2024-12-31 13F/A BRIDGEBIO PHARMA COM Put 179,300 -10.22 4,920 -3.25 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Put 179,300 4,920 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Put 199,700 14.18 5,084 14.76 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Put 174,900 79.20 4,430 46.83 n/a n/a n/a
2024-05-10 2024-03-31 13F BRIDGEBIO PHARMA COM Put 97,600 13.89 3,018 -12.78 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Put 85,700 -50.92 3,460 -24.87 n/a n/a n/a
2023-11-09 2023-09-30 13F BRIDGEBIO PHARMA COM Put 174,600 4.61 4,604 60.42 n/a n/a n/a
2023-08-09 2023-06-30 13F BRIDGEBIO PHARMA COM Put 166,900 -48.49 2,871 -46.56 n/a n/a n/a
2023-05-12 2023-03-31 13F BRIDGEBIO PHARMA COM Put 324,000 5,790.91 5,372 13,000.00 n/a n/a n/a
2023-02-09 2022-12-31 13F BRIDGEBIO PHARMA COM Put 5,500 -91.41 42 -93.55 n/a n/a n/a
2022-11-09 2022-09-30 13F BRIDGEBIO PHARMA COM Put 64,000 183.19 636 210.24 n/a n/a n/a
2022-08-11 2022-06-30 13F BRIDGEBIO PHARMA COM Put 22,600 -14.72 205 -23.79 n/a n/a n/a
2022-05-12 2022-03-31 13F BRIDGEBIO PHARMA COM Put 26,500 -87.04 269 -92.11 n/a n/a n/a
2022-02-11 2021-12-31 13F BRIDGEBIO PHARMA COM Put 204,500 804.87 3,411 222.10 n/a n/a n/a
2021-11-12 2021-09-30 13F BRIDGEBIO PHARMA COM Put 22,600 -17.82 1,059 -36.81 n/a n/a n/a
2021-08-10 2021-06-30 13F BRIDGEBIO PHARMA COM Put 27,500 -17.42 1,676 -18.28 n/a n/a n/a
2021-05-12 2021-03-31 13F BRIDGEBIO PHARMA COM Put 33,300 566.00 2,051 476.12 n/a n/a n/a
2021-02-10 2020-12-31 13F BRIDGEBIO PHARMA COM Put 5,000 356 n/a n/a n/a
2020-11-12 2020-09-30 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F BRIDGEBIO PHARMA COM Put 500 16 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.